Regulatory uncertainty 'a barrier' to issuance of contingent capital by European insurers

Davos Switzerland

Uncertainty over the development of Solvency II is preventing European insurers from issuing contingent capital instruments, according to debt capital markets bankers.

The comments come in the wake of a $750 million (£502 million) contingent capital bond issued by Swiss Re.

Contingent capital instruments are generally debt instruments that convert into equity (known as contingent convertible or ‘CoCo' bonds) or are written down once a pre-determined trigger point is reached, such as regulatory

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: